The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Progress, challenges and opportunities in fish vaccine development
Open accessAbstract
In 2014 the contribution of aquaculture to supply food for human consumption overtook wild-caught fish for the first time. Despite improvements in the aquaculture industry, it has been estimated that as much as 10% of all cultured aquatic animals are lost because of infectious diseases, amounting to >10 billion USD in losses annually on a global scale. Vaccination to prevent disease is used routinely in finfish aquaculture, especially for Atlantic salmon (Salmo salar), while in a limited capacity (or not at all) in many other fish species due to lack of vaccines, poor performance or cost. There has, nevertheless, been impressive progress in fish vaccine development over the last 4 decades with 24 licenced fish vaccines now commercially available for use in a variety of fish species. These comprise whole killed, peptide subunit, recombinant protein, DNA and live attenuated vaccines. Challenges do, however, still exist as the majority of commercial vaccines are killed whole cell pathogen preparations administered by intraperitoneal injection. This may not be the optimal route to deliver some vaccines, but lack of effective adjuvants and basic knowledge on immune response has hindered progress in the development of mucosal vaccines. The cost of injecting fish may also be prohibitive in some countries leading to disease treatment (e.g. with antibiotics) rather than using preventative measures. It is important that these issues are addressed as the industry continues to grow globally. Exciting opportunities exist for rapid development of fish vaccines in the future, with continued reduction in cost of technologies (e.g. of whole genome sequencing), regulations changing (e.g. DNA vaccines can now authorised in Europe), the introduction of novel antigen expression and delivery systems (such as virus-like particles, VLPs), development of novel adjuvants and advancements in the elucidation of basic mechanisms of mucosal immunity. Development of effective mucosal vaccines and optimisation of their delivery will facilitate novel vaccine development, and enable the aquaculture industries in LMIC to use vaccination routinely in the future. In addition, effective use of emergency (autogenous) vaccines will assist in tackling emerging disease challenges.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
mRNA vaccines — a new era in vaccinology
Pardi, N., Hogan, M. J., Porter, F. W., & Weissman, D. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.243 · Cited by 4,667
Global trends in antimicrobial use in food animals
Van Boeckel, T. P., Brower, C., Gilbert, M., Grenfell, B. T., Levin, S. A., Robinson, T. P., Teillant, A., & Laxminarayan, R. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1503141112 · Cited by 3,973
Potency testing of fish vaccines
Amend, D. F. (1980) · Medical Entomology and Zoology · Cited by 818
The Rising Tide of Antimicrobial Resistance in Aquaculture: Sources, Sinks and Solutions
Watts, J., Schreier, H., Lanska, L., & Hale, M. (2017) · Marine Drugs · doi:10.3390/md15060158 · Cited by 731
The perfect mix: recent progress in adjuvant research
Guy, B. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1681 · Cited by 620
Vaccine delivery using nanoparticles
Gregory, A. E., Titball, R., & Williamson, D. (2013) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2013.00013 · Cited by 561
Amend, D. F. (1981) · Medical Entomology and Zoology · Cited by 371
Status and future perspectives of vaccines for industrialised fin-fish farming
Brudeseth, B. E., Wiulsrød, R., Fredriksen, B. N., Lindmo, K., Løkling, K.-E., Bordevik, M., Steine, N., Klevan, A., & Gravningen, K. (2013) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2013.05.029 · Cited by 302
Oral Vaccination of Fish – Antigen Preparations, Uptake, and Immune Induction
Mutoloki, S., Munang’andu, H. M., & Evensen, Ø. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00519 · Cited by 198
The history of the smallpox vaccine
Stewart, A., & Devlin, P. M. (2005) · Journal of Infection · doi:10.1016/j.jinf.2005.07.021 · Cited by 135
Bayliss, S., Verner–Jeffreys, D. W., Bartie, K. L., Aanensen, D. M., Sheppard, S. K., Adams, A., & Feil, E. J. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00121 · Cited by 114
Self-citationFredriksen, B. N., & Grip, J. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.10.105 · Cited by 103
DNA vaccines for fish: Review and perspectives on correlates of protection
Dalmo, R. A. (2017) · Journal of Fish Diseases · doi:10.1111/jfd.12727 · Cited by 102
Ji, J., Torrealba, D., Ruyra, À., & Roher, N. (2015) · Biology · doi:10.3390/biology4040664 · Cited by 97
An Overview of Challenges Limiting the Design of Protective Mucosal Vaccines for Finfish
Munang’andu, H. M., Mutoloki, S., & Evensen, Ø. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00542 · Cited by 89
Munang’andu, H. M., Fredriksen, B. N., Mutoloki, S., Brudeseth, B. E., Kuo, T., Marjara, I. S., Dalmo, R. A., & Evensen, Ø. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.04.039 · Cited by 86
Behera, T., Nanda, P. K., Mohanty, C., Mohapatra, D., Swain, P., Das, B. K., Routray, P., Mishra, B. K., & Sahoo, S. K. (2009) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2009.11.009 · Cited by 71
A Review of the Immunological Mechanisms Following Mucosal Vaccination of Finfish
Munang’andu, H. M., Mutoloki, S., & Evensen, Ø. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00427 · Cited by 70
Fredriksen, B. N., Sævareid, K. L., McAuley, L., Lane, M. E., Bøgwald, J., & Dalmo, R. A. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.08.087 · Cited by 58
Pichia pastoris yeast as a vehicle for oral vaccination of larval and adult teleosts
Embregts, C. W. E., Reyes‐López, F. E., Pall, A., Stratmann, A., Tort, L., Lorenzen, N., Engell-Sørensen, K., Wiegertjes, G. F., Forlenza, M., Sunyer, J. O., et al. (2018) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2018.07.033 · Cited by 37
Immunology of Vaccine Adjuvants
Ribeiro, C. M. S., & Schijns, V. E. C. J. (2009) · Methods in molecular biology · doi:10.1007/978-1-60761-585-9_1 · Cited by 34
Adjuvants and Delivery Methods: Current and Novel
Dalmo, R. A., Bøgwald, J., & Tafalla, C. (2016) · Birkhäuser advances in infectious diseases · doi:10.1007/978-3-0348-0980-1_4 · Cited by 27
Development of a waterborne challenge model forFlavobacterium psychrophilum
Long, A., Fehringer, T. R., LaFrentz, B. R., Call, D. R., & Cain, K. D. (2014) · FEMS Microbiology Letters · doi:10.1111/1574-6968.12563 · Cited by 26
Vaccination against Enteric Septicemia of Catfish
Klesius, P. H., & Pridgeon, J. W. (2014) · Wiley eBooks · doi:10.1002/9781118806913.ch18 · Cited by 18
Cited by
A 20-year retrospective review of global aquaculture
Naylor, R. L., Hardy, R. W., Buschmann, A. H., Bush, S. R., Cao, L., Klinger, D. H., Little, D. C., Lubchenco, J., Shumway, S. E., & Troell, M. (2021) · Nature · doi:10.1038/s41586-021-03308-6 · Cited by 2,233
Ma, J., Bruce, T. J., Jones, E. M., & Cain, K. D. (2019) · Microorganisms · doi:10.3390/microorganisms7110569 · Cited by 424
Review of alternatives to antibiotic use in aquaculture
Bondad‐Reantaso, M. G., MacKinnon, B., Karunasagar, I., Fridman, S., Alday‐Sanz, V., Brun, E., Le Groumellec, M., Li, A., Surachetpong, W., Karunasagar, I., et al. (2023) · Reviews in Aquaculture · doi:10.1111/raq.12786 · Cited by 410
Metadata
- Authors
- Adams, A.
- Venue
- Fish & Shellfish Immunology
- Publisher
- Elsevier BV
- Published
- 2019-07
- Volume
- 90
- Pages
- 210-214
- ISSN
- 1050-4648 (ISSN-L)
- OpenAlex
- W2940558874
- Cited by
- 365
- References
- 24
- FWCI
- 11.54
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.